ArticleFrontiers in oncology2021

Prognostic Value of Baseline Medications Plus Neutrophil-to-Lymphocyte Ratio in the Effectiveness of Nivolumab and Pembrolizumab in Patients With Advanced Non-Small-Cell Lung Cancer: A Retrospective Study.

Toshiki Ogiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.